
Opening Plenary Session & Speaker
📅 Wednesday, October 8, 2025
⏰ 4:45 PM - 6:00 PM
Eric Topol, Featured Speaker
Dr. Eric Topol is this year’s conference opening speaker. He is founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, Calif. He is renowned for his transformative work in cardiology, digital health, and precision medicine. He has published over 1,300 articles, is among the top 10 most cited in the field, and is a member of the National Academy of Medicine. He authored four bestselling books, including his latest book, Super Agers: An Evidence-Based Approach to Longevity, and leads major NIH grants that promotes innovation in medicine.
Following the session with Dr. Eric Topol, there will be a limited book signing with copies of Super Agers: Evidence Based Approach to Longevity. More details will be announced soon.
Welcome from 2025 Co-Chairs

State of the Society
📅 Thursday, October 9, 2025
⏰ 11:00 AM - 12:15 PM
Shelly Sakiyama-Elbert, BMES President
Dr. Shelly Sakiyama-Elbert, president of the Biomedical Engineering Society, will deliver the annual State of the Society address at BMES2025. Dr. Sakiyama-Elbert is Vice Dean for Research and Innovation and a Professor of Biomedical Engineering at the University of Washington College of Engineering. Her research focuses on drug delivery, biomaterials, and cell transplantation for regenerative medicine. A Fellow of both BMES and AIMBE, she has published extensively and served in numerous national advisory roles. As BMES President, she is committed to fostering a collaborative, and forward-looking community that supports innovation and impact across biomedical engineering.

BMES Robert A. Pritzker Distinguished Lectureship Award
📅 Thursday, October 9, 2025
⏰ 11:00 AM - 12:15 PM
Linda Griffith, Pritzker Award Winner
Dr. Linda Griffith, this year’s recipient of the prestigious BMES Robert A. Pritzker Distinguished Lectureship Award — BMES’s premier recognition — highlights this fall’s BMES2025 Annual Meeting. Her lecture will be on Thursday, October 9. Griffith is the School of Engineering Professor of Teaching Innovation in the Department of Biological Engineering at MIT and is widely recognized for her groundbreaking work in biological engineering, blending cutting-edge research with a commitment to advancing education and innovation. Grifith is a member of the National Academy of Engineering, and elected into the National Academy of Medicine for her pioneering work in tissue engineering, biomaterials, and systems biology, including developing the first “liver chip” technology. She established MIT’s Biological Engineering Department.
-
Pritzker Lecture Topic
Mice, or Microfluidics? Humanizing Biomedical Research with “NAMs”
Research and development in chronic inflammatory diseases – which often skew female – is hindered by the use of poorly representative animal models for disease mechanisms and therapeutic validation. The animal-human gaps, especially in immunology, have spurred two concurrent technological developments that are now merging: systems biology/immunology analysis of patients, and microphysiological systems (aka “organs on chips”, or living patient avatars). The NIH, which now refers to these approaches as “Novel Approach Methods” (NAMs) has launched the “Complement-ARIE” (Complement Animal Research In Experimentation) program to bolster technology development and deployment in this merger. Gynecology presents fascinating opportunities for setting the performance bar for new technologies that will have broad applicability in all of biomedical research, as illustrated the case study in drug development for endometriosis, where control of steroid hormones is essential for physiology.
Workshop & Webinar: Fundamentals and Perspectives in Medical Product Regulation for Biomedical Engineers
Fundamentals of Medical Product Regulation BMES Certificate of Participation
WEBINAR:
📅 Wednesday, September 10, 2025
⏰ 2:00 PM ET
WORKSHOP:
📅 Friday, October 10, 2025
⏰ 3:00 PM - 4:30 PM
Participation in both the virtual webinar and the in-person workshop at the BMES 2025 Annual Meeting will fulfill the requirements for completing a BMES certificate of participation program on the fundamentals of medical product regulation. The certificate program is designed for industry professionals who want to expand their knowledge of regulatory science.
The goal of the webinar is to provide motivation to learn more about regulatory science and to understand the context for the modern regulatory framework. The webinar will cover a brief history of medical product regulation in the US, fundamental laws that enable modern medical product regulation, and regulatory philosophies. It will include the FDA’s risk-based approach to regulatory burden, the shift away from reactive to proactive regulation, and the balance of minimizing public health risk with fostering innovation.
The workshop at the Annual Meeting will impart the fundamentals of translation and regulation of drugs, biologics, and devices in the US, as well as regulatory perspectives from experts in academia and industry.
All participants must register for the BMES 2025 Annual Meeting and purchase a $25 workshop ticket which provides access to both the virtual webinar and the in-person workshop.

Dr. Wendy Brown
Moderator
Dr. Wendy Brown is the Director of Regulatory and Clinical Affairs at Cartilage Inc., a biotechnology start-up company she co-founded to commercialize her team’s engineered cartilage technologies. Cartilage Inc. is pursing an IND for their engineered cartilage implant to heal defects in the TMJ disc complex. Dr. Brown leads Cartilage Inc.’s regulatory strategy, FDA interactions, and clinical start-up activities. Dr. Brown earned her Bachelors Degree in BME from the Georgia Institute of Technology, her Ph.D. in Biomedical Engineering from the University of California Davis, and her M.S. in Regulatory Science at the University of Southern California. Dr. Brown is also an Associate Research and Translational Specialist at the University of California Irvine where research focuses on translational cartilage tissue engineering for the nose and knee and cartilage tissue engineering in microgravity on the International Space Station.
Science Communications & Policy Workshop
📅 Saturday, October 11, 2025
⏰ 2:30 PM - 4:00 PM
Join us to find your power as a science communicator and come away with tools and resources to build your sci-comm portfolio. First, learn from Katie Orenstein, CEO of the OpEd Project on identifying the source of credibility; the patterns and elements of persuasion; the difference between being “right” and being effective; how to preach beyond the choir; and how to think bigger—to have more impact in the world. Then, learn from Dr. Tepring Piquado, CEO of the National Science Policy Network on how policies are made and how to leverage your credibility to influence them. She will discuss strategies for tailoring your message to policymakers and the public; building trust; and framing complex findings in ways that drive real-world decisions. Whether you’re new to science communication or looking to refine your approach, you’ll leave with practical tools and inspiring examples to help your research shape policies that matter. Both speakers will leave us with follow on options for additional training and interaction.

Dr. Tepring Piquado

Katie Orenstein
-
Learn More About the Speakers
Katie Orenstein, CEO of the OpEd Project
“Write to Change the World” from 2:30 PM – 3:30 PMMs. Orenstein, the founder and CEO of the OpEd project is a successful author and dynamic communicator, who will explore with the group what it means to be an expert. Participants will have time to explore ideas about credibility, authority, and knowledge. “Write To Change the World” is a discovery-based interrogation of authority and knowledge. It walks participants through a method for changing hearts and minds. The world becomes more intelligent when we access all our intelligence. The OpEd Project believes that the best ideas, no matter where they come from, should have a chance to be heard and to change the world.
Dr. Tepring Piquado, CEO of the National Science Policy Network
“Beyond the Paper: Science Communication as a Tool for Making an Impact” from 3:30 PM - 4:00 PMDr. Tepring Piquado will teach participants how to best target their outreach and science communication for maximum impact. Scientists produce knowledge that can transform communities, economies, and the environment—yet too often that knowledge stays within academic circles. This session explores how to go beyond publishing papers and effectively communicate science to influence policy. We’ll discuss strategies for tailoring your message to policymakers and the public; building trust and credibility; and framing complex findings in ways that drive real-world decisions. Whether you’re new to science communication or looking to refine your approach, you’ll leave with practical tools and inspiring examples to help your research shape policies that matter.
Dr. Piquado is a seasoned policy researcher, government relations expert, and science advisor whose work bridges the worlds of science, technology, and public policy. She currently serves as CEO of the National Science Policy Network, where she leads efforts to connect STEM researchers with opportunities to inform evidence-based policymaking. She has served as a consultant, lobbyist, and government relations specialist, working with local, state, and federal officials and nonprofit leaders to translate research into actionable policy. At RAND Corporation, she led research projects supporting evidence-based decisions at every level of government and taught ethics and policy design at the RAND Graduate School of Public Policy. Dr. Piquado holds a Ph.D. and M.S. in neuroscience from Brandeis University and a B.S. in computer science from Georgetown University.
Are you planning to attend this workshop?
Robert A. Pritzker Distinguished Lecture Roundtable & Meet-and-Greet Shu Chien
📅 Saturday, October 11, 2025
⏰ 4:35 PM - 5:30 PM
We’ve invited recipients of the prestigious Pritzker Award to a special roundtable, moderated by BMES President Shelly Sakiyama-Elbert, centered on the state of biomedical engineering—everything from the latest advances to research funding.
Professor Shu Chien, MD, PhD, past President of BMES, AIMBE, APS, and FASEB will be on hand to provide introductory remarks. Dr. Chien is internationally recognized as one of the foremost pioneers and educators in biomedical engineering.

Dr. Shelly Sakiyama-Elbert
BMES President & Moderator

Dr. Shu Chien
Opening Remarks with a Post-Session Meet & Greet
Conference Keynote I - Rethinking the Grants Model: Embracing New Research Funding Opportunities
📅 Saturday, October 11, 2025
⏰ 6:30 PM - 8:00 PM
The impact of federal research funding cuts to members of our community has left us with a significant void and much uncertainty.
Join one of the most important conversations of the year as experts from industry, philanthropy, and government share opinions, ideas, and insights on how biomedical engineers and other researchers should consider soliciting funding from channels outside of federal grants.
There will be a Q&A session at the end of the session. We will ask that you submit your questions prior to the event.
The panelists below are the ones who have been confirmed so far. Please check back often as additional panelists accept our invitation to participate.
-
Learn More About the Speakers
Taya Cassens is a Senior Principal Systems Technology Engineer at Medtronic, where she develops next-generation technologies for cardiac implantable devices, focusing on novel strategies for diagnosing, pacing, and protecting patients with arrhythmias. She has contributed across the medical device lifecycle, including 6 years at Medtronic working on deep brain stimulation, heart valves, defibrillation, and diagnostic devices, and earlier in her career supported military power generation systems with Cummins and structural heart innovation at Boston Scientific.
Taya holds a B.S. in Mechanical Engineering from the University of Missouri, Kansas City and dual M.S. degrees in Mechanical Engineering and Systems Engineering from the University of St. Thomas. She is also a licensed Professional Engineer in the state of Minnesota.
Taya is also a leader with the Society of Women in Engineering and has been deeply involved with outreach to University partners in the United States and beyond. Taya is connected with other thought leaders at Medtronic who interact with overseas entities that link government-universities and for-profits like Medtronic.
Ishita Das, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy, where she leads cross-disciplinary projects. Her expertise lies in biomedical research, science policy, stakeholder engagement, workforce diversity, strategic planning, and project management. At the Milken Institute, she applies this knowledge to guide philanthropic investments to have a meaningful impact on science and health. Das advises philanthropists and foundations and implements strategies to deploy philanthropic capital to advance health research priorities. Previously, Das was at a management consulting firm, where she led cross-functional teams to implement science and health initiatives for federal agencies, nonprofits, and public-private partnerships, including the National Institutes of Health, the Office for Human Research Protections, the National Human Genome Research Institute, the National Institute of Environmental Health Sciences, the Patient-Centered Outcomes Research Institute, and the Centers for Medicare & Medicaid Services. Das received her bachelor's degree in biology from the University of North Carolina, Chapel Hill, and her doctorate in cellular and molecular biology from the University of Michigan, Ann Arbor.
Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.
He is a Co-Founding Partner at Saybrook Capital (“Saybrook”), an investment banking and private equity firm based in Santa Monica, California. In his legal career prior to Saybrook, Thomas clerked for White House Counsel Lloyd Cutler in the last year of the Carter Administration and for the Honorable George Mackinnon in the United States Circuit Court of Appeals for the District of Columbia Circuit. He later practiced at Munger, Tolles & Olson in Los Angeles.
Long interested in the biological sciences, Thomas majored in Biology and History at Yale, where he graduated summa cum laude. As a George C. Marshall Scholar at Oxford, he then earned a PhD with a medical focus in Commonwealth History. He subsequently returned to Yale for a JD at the Yale Law School. While there, Thomas retained an involvement with biology by teaching courses on the legal implications of genetic engineering and the impact of disease on history.
Thomas has a long-standing commitment to patient advocacy. He spent more than 15 years on the Board of the Crippled Children’s Society of Southern California and served as chair for four years. The organization, now called AbilityFirst, assists children with spinal cord injuries and mental disabilities that could be targets of stem cell therapies. Thomas is an Honorary member of the AbilityFirst Board.
Conference Keynote II - The Impact of AI in Biomedical Engineering Innovation: A Conversation with Clinicians and Biomedical Engineers
📅 Sunday, October 12, 2025
⏰ 10:00 AM - 11:00 AM
Join this impressive panel of leading AI thinkers as they discuss the present state and the future of artificial intelligence in healthcare applications and biomedical pedagogy.

Dr. Daniel Kraft
Founder & Chair, NextMed Health, Moderator
-
Learn More About the Moderator
Dr. Daniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, and in 2011 founded NextMed Health (previously called Exponential Medicine) a program and community that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He serves as Chair of the XPRIZE Pandemic & Health Alliance.
Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology, and bone marrow transplantation at Stanford.
Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is member of the Kauffman Fellows Society. He is a managing partner with Continuum Health Ventures which is focused on funding early stage health tech companies enabling the democratization of health and improved healthspan for all.
He is often called upon to speak to the future of health, medicine and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations.
He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.
Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His research has been published in journals that include Nature and Science. His clinical work has focused on: bone marrow & hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine.
He is heavily involved in digital health, founded Digital.Health, is on the board of Healthy.io and advises several Fortune-50 and digital health-related startups. Daniel recently founded IntelliMedicine, focused on personalized, data-driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies.
Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
-
Learn More About the Speakers
Dr. Brian Anderson is the Chief Executive Officer of the Coalition for Health AI (CHAI), a non-profit coalition he co-founded in 2021. CHAI is focused on developing a set of consensus-driven guidelines and best practices for Responsible AI in Health, as well as supporting the ability to independently test and validate AI for safety and effectiveness.
Prior to leading CHAI, Dr. Anderson was the Chief Digital Health Physician at MITRE, where he led research and development efforts across major strategic initiatives in digital health alongside industry partners and the U. S. Government. He was responsible for leading much of MITRE’s work during the COVID-19 pandemic, working closely with the White House COVID Task Force, as well as Operation Warp Speed. He also led MITRE’s largest R&D effort in Oncology, focusing on the initial development of mCODE and the use of AI in more efficient and inclusive clinical trial design.
Dr. Anderson is an internationally recognized author and expert in digital health, and is regularly engaged as a speaker on digital health innovation, health standards development, clinical decision support systems, and interoperability. Prior to MITRE, Anderson led the Informatics and Network Medicine Division at athenahealth. He has also served on several national, and international, health information technology committees in partnership with the Office of the National Coordinator (ONC), the National Institutes of Health (NIH) and the Organization for Economic Cooperation and Development (OECD).
Dr. Michael King is a national leader in the field of biomedical engineering, and an expert in the following research areas: the adhesion and transport of circulating cells; cellular delivery of anti-cancer therapeutics in the bloodstream; the mechanotransduction of cancer and immune cells in shear flow; and the development of 3D in vitro models of bloodborne metastasis. Dr. King completed a PhD in chemical engineering at the University of Notre Dame and postdoctoral training in bioengineering at the University of Pennsylvania. He has written textbooks on the subjects of statistical methods and microchannel flows, and has received several awards including the NSF CAREER Award, Outstanding Research Awards from the American Society of Mechanical Engineers and the American Society of Clinical Chemistry, and was a James D. Watson Investigator of New York State. King is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), International Academy of Medical and Biological Engineering (IAMBE), American Association for the Advancement of Science (AAAS), and the National Academy of Inventors (NAI), and served as founding Vice President of the International Society of Bionic Engineering. Since 2013 he has been the Editor-in-Chief of Cellular and Molecular Bioengineering, an official journal of the BMES. He previously served as Chair of the BME Council of Chairs, and most recently as the Chair of the AIMBE College of Fellows.
Prior to joining the Rice faculty in 2024, Michael R. King was the J. Lawrence Wilson Professor and Department Chair of Biomedical Engineering at Vanderbilt University. Before that he was the Daljit S. and Elaine Sarkaria Professor at Cornell University, and he started his faculty career at the University of Rochester.
Dr. Rui Carlos Pereira de Sá is a biomedical engineer and physiologist. Throughout his career, he developed, validated and deployed computational techniques able to produce quantitative insight on the human lung in health and disease. He is an Engineer in Physics (Instituto Superior Técnico, Lisbon, Portugal); his Ph.D. work (Université Libre de Bruxelles, Brussels, Belgium), focused on understanding the impact of gravity on respiratory mechanics during sleep, through human studies on earth and in two space shuttle flights. Attaining this goal required developing algorithms using artificial neural networks for breath detection during sleep and wavelet analysis.
Prior to joining the NIH, Dr. Sá was an Assistant Professor of Physiology, Division of Pulmonary, Critical Care, Sleep Medicine, and Physiology at the University of California, San Diego. Since 2008 his main research tool was functional Magnetic Resonance Imaging (MRI) of the lung, namely a proton MR technique – Specific Ventilation Imaging - capable of quantifying ventilation in the human lung. Specific Ventilation Imaging uses inhaled oxygen as a T1 contrast agent, to create quantitative map specific ventilation. The SVI technique is now available at several centers on three continents, and is used to further out understanding of asthma, cystic fibrosis, and other respiratory diseases.
Dr. Sá first joined NIH and NIBIB as NIH Data and Technology Advancement (DATA) National Service Scholar (2020-2022), on detail from the University of California, San Diego. His profound knowledge of lung physiology, combined with years of experience in developing, validating and translating quantitative analysis software tools directly applicable to the lung were aligned with and necessary for addressing the immediate and urgent need for Covid-19 imaging processing tools. Accelerating the deployment of AI/ML image processing tools is the priority for NIBIB’s Medical Imaging and Data Resource Center (MIDRC) project, a project he actively supported for the duration of his National Service Scholarship. Dr. Sá rejoined the NIH as a Program Director in 2023.
Workshop: Optimized Data-Driven AI for Biomedical Data Analysis
In partnership with MathWorks. BMES Certificate of Participation
📅 Sunday, October 12, 2025
⏰ 11:00 AM - 2:00 PM
In recent years, the integration of artificial intelligence (AI) techniques has revolutionized biomedical data analysis. Researchers can leverage AI to extract valuable insights from biomedical data, enabling more accurate diagnostics, personalized monitoring, and effective treatment strategies. As AI technologies continue to advance rapidly, their integration into biomedical data analysis offers the potential for improved accuracy, efficiency, and automation. There is a growing demand for advanced techniques for predictive diagnosis and monitoring, early disease detection, and personalized treatment pathways in healthcare. This session explores the potential of AI algorithms, including machine learning and deep learning, to enhance biomedical data interpretation. We will discuss techniques for reducing computational complexity and performing structural and data-type compression without compromising the performance of AI models. By the end of the workshop, participants will have a comprehensive understanding of the techniques and tools necessary to implement and optimize AI-driven biomedical data processing for deployment in healthcare, fitness, and biomedical research.
The workshop is open to all conference attendees who have prepaid the $25 workshop fee when registering for the annual meeting.
-
Topics That Will Be Covered:
During an interactive session, participants will explore the following topics:
-
Introduction to tools used for AI-based data processing
-
Detection of seizure in EEG using a time-frequency-based convolutional neural network
-
Classification of brain MRI using deep learning
-
Optimization of signal source separation algorithm using a convolutional neural network
This workshop aims to provide participants with an understanding of the potential applications of AI to incorporate AI algorithms in processing, analyzing, and interpreting complex biomedical data. Additionally, the workshop will showcase cutting-edge AI-powered tools, methodologies, and resources that streamline the development of machine learning algorithms and deep learning models. The workshop is suitable for individuals with all levels of experience in data processing. While no prior knowledge is required, experienced users will benefit from the introduction of new tools, tips, and tricks for applying advanced techniques to biomedical data processing.
-
-
Learn More About the Moderator
Reza Fazel-Rezai, Ph.D., Senior Science and Education Application Engineer, MathWorks
Dr. Reza Fazel-Rezai, with a Ph.D. and MS in Biomedical Engineering and a BS in Electrical Engineering, brings over two decades of experience in both industry and academia. As a senior research scientist, research team manager, and the founding Director and tenured full Professor of Biomedical Engineering, he has extensive expertise and background in the field. Dr. Fazel-Rezai has authored more than 200 scientific publications, edited and published seven books, and pursued diverse research interests in biomedical signal and image processing, particularly through machine learning and deep learning methods. Passionate about leveraging and sharing his skills to help others achieve their goals, he currently serves as an ABET PEV for Biomedical Engineering, works part-time as an instructor at UC San Diego, and is a full-time Senior Science and Education Application Engineer at MathWorks.

Dr. Reza Fazel-Rezai

Contact
1101 Wilson Boulevard
6th Floor - Suite 953
Arlington, VA 22209
Contact Us
(301) 459-1999
Quick Links
About BMES
BMES is the premier professional community for biomedical engineering innovation and excellence. Our vibrant organization unites more than 6,700 members and a network of over 25,000 across academia, industry, and healthcare, supported by 110+ student chapters worldwide. Through our conferences, specialized interest groups, four leading journals and a myriad of initiatives, we drive advances in medical technology, research, and patient care. Join us in shaping the future of healthcare through engineering.